AZTR

NYSEAMERICAN 已收盘

Azitra

0.52 USD
▼-0.01-2.75%
盘后 0.50 -3.13%
2026-11-20
市值
$3.13M
市盈率
—
EPS
-3.10
股息率
—
52 周区间
0.51 – 3.91
成交量
56.19K
Beta
-0.89
目标价
3.50
52W 低 0.5152W 高 3.91
价格走势

公司简介

Azitra, Inc., an early-stage clinical biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and topical live biotherapeutic products to treat skin diseases in the United States. The company develops ATR-04, a genetically modified strain of S. epidermidis that is in a Phase 1/2 clinical trial for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor targeted therapy; ATR-12, a genetically modified strain of S. epidermidis, which is in a Ph...